Leading International Investment Research

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Leading International Investment Research, Edison Investment Research

Equity Bottom-Up

<p>The NDA submission for illumet has been delayed slightly by COVID-19 but is expected to be submitted in Q220 (from March-April guidance). A European MAA has already been submitted. Telix’s clinical studies (including the ZIRCON Phase III study that recently opened enrolment in the US) are paused, but the company expects them to reopen in June and be back to normal around September. Telix is now guiding to ZIRCON full enrolment by the end of 2020.</p>

The NDA submission for illumet has been delayed slightly by COVID-19 but is expected to be submitted in Q220 (from March-April guidance). A European MAA has already been submitted. Telix’s clinical studies (including the ZIRCON Phase III study that recently opened enrolment in the US) are paused, but the company expects them to reopen in June and be back to normal around September. Telix is now guiding to ZIRCON full enrolment by the end of 2020.

Telix Pharmaceuticals - Making progress despite headwinds